Michael Katz
Psychiatry · Norwell, MANPI 1932211653
Payments from drug & device makers
Across 188 payments — averaging $16.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$944
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$483
- Lundbeck LLC$321
- Sunovion Pharmaceuticals Inc.$293
- Corium, LLC$192
- Alkermes, Inc.$190
- plus $757 from 13 others
What the payments were for
- Food & beverage$3,12898%
- Education$522%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 61 | $944 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 31 | $483 |
| Lundbeck LLC | 18 | $321 |
| Sunovion Pharmaceuticals Inc. | 12 | $293 |
| Corium, LLC | 11 | $192 |
| Alkermes, Inc. | 10 | $190 |
| Merck | 10 | $152 |
| Teva Pharmaceuticals USA, Inc. | 7 | $142 |
| Alnylam Pharmaceuticals Inc. | 5 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $63 |
| Eisai Inc. | 4 | $58 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Jazz Pharmaceuticals Inc. | 3 | $45 |
| Idorsia Pharmaceuticals US Inc | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Johnson & Johnson | 2 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Harmony Biosciences LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,180 in reported general payments places this provider in the 85th percentile of 1,431 psychiatry providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 12 | $11,014 |
| FetzimaLevomilnacipran Hcl | 22 | $10,890 |
| DayvigoLemborexant | 14 | $5,474 |
| Buspirone Hcl | 68 | $3,773 |
| Duloxetine Hcl | 30 | $2,780 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 31 | $2,617 |
| Bupropion XlBupropion Hcl | 105 | $2,553 |
| Paroxetine ErParoxetine Hcl | 17 | $1,808 |
| Clomipramine Hcl | 11 | $1,487 |
| Lamotrigine | 100 | $1,413 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 58 | $1,276 |
| Aripiprazole | 36 | $1,193 |
| Quetiapine Fumarate | 50 | $987 |
| Mirtazapine | 52 | $734 |
| Trazodone Hcl | 58 | $682 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $63 | $11,01412 claims |
| AbbVieFetzima | $944 | $10,89022 claims |
| Eisai Inc.Dayvigo | $58 | $5,47414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,431 psychiatry providers in Massachusetts.
Other psychiatry in Norwell
- Lee CohenBoston$7M
- Dyanna DomiliciBoston$5.8M
- Arkadiy StolyarBelmont$3.3M
- Maurizio FavaBoston$2.8M
- Marc ShayAmesbury$1.7M
- Martha StarkNewton$1.6M
- Hadine JoffeBoston$1.5M
- Malini NairWinchester$1M
- Xiaoduo FanWorcester$950K
- Anthony RothschildWorcester$838K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.